Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 03, 2023

SELL
$77.31 - $88.08 $3,556 - $4,051
-46 Reduced 3.87%
1,143 $94,000
Q4 2022

Feb 06, 2023

BUY
$62.32 - $89.47 $3,676 - $5,278
59 Added 5.22%
1,189 $102,000
Q3 2022

Nov 08, 2022

SELL
$59.54 - $68.01 $416 - $476
-7 Reduced 0.62%
1,130 $70,000
Q2 2022

Jul 19, 2022

BUY
$57.72 - $65.01 $25,223 - $28,409
437 Added 62.43%
1,137 $70,000
Q1 2022

Apr 29, 2022

SELL
$57.92 - $72.58 $15,754 - $19,741
-272 Reduced 27.98%
700 $41,000
Q4 2021

Jan 24, 2022

BUY
$64.88 - $73.64 $16,739 - $18,999
258 Added 36.13%
972 $71,000
Q3 2021

Oct 29, 2021

BUY
$67.69 - $73.03 $1,963 - $2,117
29 Added 4.23%
714 $50,000
Q2 2021

Aug 02, 2021

BUY
$63.47 - $69.35 $3,173 - $3,467
50 Added 7.87%
685 $47,000
Q1 2021

Apr 29, 2021

SELL
$60.0 - $68.46 $11,520 - $13,144
-192 Reduced 23.22%
635 $41,000
Q4 2020

Jan 21, 2021

BUY
$56.65 - $64.55 $906 - $1,032
16 Added 1.97%
827 $48,000
Q3 2020

Oct 20, 2020

SELL
$62.1 - $78.08 $869 - $1,093
-14 Reduced 1.7%
811 $51,000
Q2 2020

Jul 20, 2020

BUY
$72.34 - $84.0 $13,816 - $16,044
191 Added 30.13%
825 $63,000
Q1 2020

Apr 14, 2020

SELL
$62.63 - $80.22 $7,327 - $9,385
-117 Reduced 15.58%
634 $47,000
Q4 2019

Jan 27, 2020

BUY
$61.62 - $67.78 $308 - $338
5 Added 0.67%
751 $49,000
Q3 2019

Oct 17, 2019

SELL
$62.51 - $69.0 $3,750 - $4,140
-60 Reduced 7.44%
746 $47,000
Q2 2019

Jul 23, 2019

SELL
$61.87 - $69.38 $3,588 - $4,024
-58 Reduced 6.71%
806 $54,000
Q1 2019

Apr 11, 2019

BUY
$62.53 - $70.05 $6,065 - $6,794
97 Added 12.65%
864 $56,000
Q4 2018

Jan 17, 2019

SELL
$60.54 - $79.0 $605 - $790
-10 Reduced 1.29%
767 $48,000
Q3 2018

Nov 02, 2018

SELL
$71.28 - $78.92 $16,964 - $18,782
-238 Reduced 23.45%
777 $60,000
Q2 2018

Jul 27, 2018

SELL
$64.88 - $75.68 $454 - $529
-7 Reduced 0.68%
1,015 $72,000
Q1 2018

Apr 30, 2018

SELL
$72.84 - $88.8 $1,383 - $1,687
-19 Reduced 1.83%
1,022 $77,000
Q4 2017

Feb 01, 2018

SELL
$71.15 - $83.52 $213 - $250
-3 Reduced 0.29%
1,041 $75,000
Q3 2017

Oct 24, 2017

SELL
$72.11 - $85.47 $15,647 - $18,546
-217 Reduced 17.21%
1,044 $85,000
Q2 2017

Aug 10, 2017

BUY
N/A
1,261
1,261 $89,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Tci Wealth Advisors, Inc. Portfolio

Follow Tci Wealth Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.